However, they mediate antibody‐dependent cellular cytotoxicity (ADCC) by producing tumor‐specific IgG1 antibodies, which bind Fc gamma receptors (FcγR), promoting tumor cell clearance and positively correlating with patient prognosis [39]. Here, FCGR2A is linked to neoplasm.